Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-23-009149
Filing Date
2023-02-01
Accepted
2023-02-01 13:38:34
Documents
1
Group Members
CASEY M. TANSEYJONATHAN D. ROOTPRESIDIO MANAGEMENT GROUP XI, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm235047d1_sc13da.htm SC 13D/A 66894
  Complete submission text file 0001104659-23-009149.txt   68453
Mailing Address 2735 SAND HILL ROAD MENLO PARK CA 94025
Business Address 2735 SAND HILL ROAD MENLO PARK CA 94025 (650) 854-9080
U.S. Venture Partners XI, L.P. (Filed by) CIK: 0001619539 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 3415 COLORADO AVE. BOULDER CO 80303
Business Address 3415 COLORADO AVE. BOULDER CO 80303 303-735-8373
Edgewise Therapeutics, Inc. (Subject) CIK: 0001710072 (see all company filings)

EIN.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92424 | Film No.: 23575962
SIC: 2834 Pharmaceutical Preparations